ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 99 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $285,000 | +32.6% | 15,834 | +85.5% | 0.00% | 0.0% |
| Q1 2021 | $215,000 | +35.2% | 8,537 | -89.8% | 0.00% | 0.0% |
| Q4 2019 | $159,000 | +23.3% | 83,924 | +42.5% | 0.00% | 0.0% |
| Q2 2019 | $129,000 | -53.1% | 58,902 | +28.3% | 0.00% | -66.7% |
| Q1 2019 | $275,000 | -66.9% | 45,906 | -59.2% | 0.00% | -70.0% |
| Q4 2018 | $832,000 | +82.9% | 112,590 | +258.9% | 0.01% | +100.0% |
| Q3 2018 | $455,000 | +58.5% | 31,370 | +118.2% | 0.01% | +25.0% |
| Q2 2018 | $287,000 | -58.0% | 14,375 | -63.2% | 0.00% | -63.6% |
| Q1 2018 | $684,000 | +41.3% | 39,058 | +99.1% | 0.01% | +37.5% |
| Q4 2017 | $484,000 | +66.3% | 19,616 | +82.7% | 0.01% | -33.3% |
| Q4 2016 | $291,000 | – | 10,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |